Latest Stock Split Details
Key information about CNS Pharmaceuticals, Inc.'s most recent stock split
Split Date: 2025-07-22
Split Ratio: 1:12
Price Before Split: $0.73
Price After Split: $0.06
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 12.00 times fewer shares (a 1:12 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of CNS Pharmaceuticals, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2025-07-22 | 1:12 | Yes | $0.73 | $0.06 |
| 2025-02-21 | 1:50 | Yes | $0.01 | $0.00 |
| 2024-06-05 | 1:50 | Yes | $0.01 | $0.00 |
| 2022-11-29 | 1:30 | Yes | $0.01 | $0.00 |
About CNS Pharmaceuticals, Inc.
Company overview and industry information
CNS Pharmaceuticals, Inc. (CNSP) operates in the Biotechnology industry. The recent 1-for-12 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to CNS Pharmaceuticals, Inc. Summary